{"id":"W2170990838","doi":"10.1161/01.cir.0000087404.53661.f8","title":"Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction","year":2003,"lang":"en","type":"article","venue":"Circulation","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":176,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Heart Institute; University of Alberta","funders":"Alexion Pharmaceuticals; Procter and Gamble","keywords":"Medicine; Bolus (digestion); Placebo; Myocardial infarction; Fibrinolysis; Anesthesia; Infarction; Cardiology; Creatine kinase; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001474117,0.0009111367,0.001982874,0.0004004677,0.0002347866,0.0005675299,0.0005904599,0.001048177,0.001968761],"category_scores_gemma":[0.001887846,0.0003682537,0.0009238331,0.0003771729,0.0006180027,0.0004161278,0.0002509615,0.001655364,0.0002461655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005002992,"about_ca_system_score_gemma":0.000692544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005272291,"about_ca_topic_score_gemma":0.001344969,"domain_scores_codex":[0.9993142,0.000405917,0.00006705904,0.00008609877,0.00005906741,0.0000676982],"domain_scores_gemma":[0.9990047,0.0004450081,0.000238285,0.00005297239,0.00004732479,0.0002118566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9366644,0.007504087,0.001870384,0.0007841285,0.001205758,0.00007134143,0.00003850762,0.0002879406,0.00926067,0.00007828891,0.0003959518,0.04183852],"study_design_scores_gemma":[0.7719894,0.2106153,0.01166779,0.0001071194,0.001250286,0.0001315545,0.0000176307,0.0005928218,0.002741753,0.00008888771,0.0007815199,0.00001585926],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990622,0.007620654,0.0002042706,0.0002553143,0.0001363718,0.000357872,0.0001188035,0.00002335722,0.0006613116],"genre_scores_gemma":[0.9944911,0.003242098,0.0006424288,0.0003002154,0.0003184186,0.000418469,0.0002049986,0.000005224677,0.0003769787],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001982874,"threshold_uncertainty_score":0.00779593,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01444646673509572,"score_gpt":0.3128439333834195,"score_spread":0.2983974666483238,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}